Hybrid BioSystems Company
Hybrid BioSystems develops gene therapy treatments for ovarian and prostate cancer. It exploits the interface between polymer chemistry.
Technology:
Cancer
Industry:
Women Cancer Treatment
Headquarters:
Upper Heyford, Somerset, United Kingdom
Funding Status:
M&A
Register and Claim Ownership